Table 1.
Clinical disease-related features and concomitant treatment in enrolled patients (N = 12).
| Disease-related features | N (%) |
|---|---|
| Mucocutaneous manifestations | 10 (83.3) |
| Musculoskeletal manifestations | 12 (100) |
| Serositis | 1 (8.3) |
| Kidney involvement | 2 (16.6) |
| Hematological manifestations | 5 (41.6) |
| Neurological manifestations | 2 (16.6) |
| Thrombotic events | 2 (16.6) |
| Immunological abnormalities | N (%) |
| ANA | 12 (100) |
| anti-dsDNA | 12 (100) |
| anti-Sm/RNP | 2 (16.6) |
| Antiphospholipid antibodies | 5 (41.6) |
| Low C3/C4 levels | 6 (50) |
| Concomitant treatments | N (%) |
| Glucocorticoids | 8 (66.6) |
| Hydroxychloroquine | 11 (91.6) |
| Methotrexate | 1 (8.3) |
| Azathioprine | 2 (16.6) |
| Cyclosporine A | 3 (25) |